Top

Journal of Cancer Research and Clinical Oncology

Published in:

01-07-2017 | Original Article – Cancer Research

Curcumin induces G2/M arrest, apoptosis, NF-κB inhibition, and expression of differentiation genes in thyroid carcinoma cells

Authors: Suzan Schwertheim, Frederik Wein, Klaus Lennartz, Karl Worm, Kurt Werner Schmid, Sien-Yi Sheu-Grabellus

Published in: Journal of Cancer Research and Clinical Oncology | Issue 7/2017

Abstract

Purpose

The therapy of unresectable advanced thyroid carcinomas shows unfavorable outcome. Constitutive nuclear factor-κB (NF-κB) activation in thyroid carcinomas frequently contributes to therapeutic resistance; the radioiodine therapy often fails due to the loss of differentiated functions in advanced thyroid carcinomas. Curcumin is known for its anticancer properties in a series of cancers, but only few studies have focused on thyroid cancer. Our aim was to evaluate curcumin’s molecular mechanisms and to estimate if curcumin could be a new therapeutic option in advanced thyroid cancer.

Methods

Human thyroid cancer cell lines TPC-1 (papillary), FTC-133 (follicular), and BHT-101 (anaplastic) were treated with curcumin. Using real-time PCR analysis, we investigated microRNA (miRNA) and mRNA expression levels. Cell cycle, Annexin V/PI staining, and caspase-3 activity analysis were performed to detect apoptosis. NF-κB p65 activity and cell proliferation were analyzed using appropriate ELISA-based colorimetric assay kits.

Results

Treatment with 50 μM curcumin significantly increased the mRNA expression of the differentiation genes thyroglobulin (TG) and sodium iodide symporter (NIS) in all three cell lines and induced inhibition of cell proliferation, apoptosis, and decrease of NF-κB p65 activity. The miRNA expression analyses showed a significant deregulation of miRNA-200c, -21, -let7c, -26a, and -125b, known to regulate cell differentiation and tumor progression. Curcumin arrested cell growth at the G2/M phase.

Conclusions

Curcumin increases the expression of redifferentiation markers and induces G2/M arrest, apoptosis, and downregulation of NF-κB activity in thyroid carcinoma cells. Thus, curcumin appears to be a promising agent to overcome resistance to the conventional cancer therapy.

Ali S, Ahmad A, Aboukameel A, Bao B, Padhye S, Philip PA et al (2012) Increased Ras GTPase activity is regulated by miRNAs that can be attenuated by CDF treatment in pancreatic cancer cells. Cancer Lett 319:173–181CrossRefPubMedPubMedCentral

Bao B, Li Y, Ahmad A, Azmi AS, Bao G, Ali S et al (2012) Targeting CSC-related miRNAs for cancer therapy by natural agents. Curr Drug Targets 13:1858–1868CrossRefPubMedPubMedCentral

Batth BK, Tripathi R, Srinivas UK (2001) Curcumin-induced differentiation of mouse embryonal carcinoma PCC4 cells. Differentiation 68:133–140CrossRefPubMed

Braun J, Hoang-Vu C, Dralle H, Hüttelmaier S (2010) Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas. Oncogene 29:4237–4244CrossRefPubMed

Chendil D, Ranga RS, Meigooni D, Sathishkumar S, Ahmed MM (2004) Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3. Oncogene 23:1599–1607CrossRefPubMed

Choudhuri T, Pal S, Das T, Sa G (2005) Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependent manner. J Biol Chem 280:20059–20068CrossRefPubMed

Cowland JB, Hother C, Grønbæk K (2007) MicroRNAs and cancer. Apmis 115:1090–1106CrossRefPubMed

Feng X, Wang Z, Fillmore R, Xi Y (2014) MiR-200, a new star miRNA in human cancer. Cancer Lett 344:166–173CrossRefPubMed

Friedman JM, Jones PA (2009) MicroRNAs: critical mediators of differentiation, development and disease. Swiss medical weekly 139:466PubMedPubMedCentral

Fröhlich E, Wahl R (2014) The current role of targeted therapies to induce radioiodine uptake in thyroid cancer. Cancer Treat Rev 40:665–674CrossRefPubMed

Gupta SC, Hevia D, Patchva S, Park B, Koh W, Aggarwal BB (2012a) Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy. Antioxid Redox Signal 16:1295–1322CrossRefPubMedPubMedCentral

Gupta SC, Patchva S, Koh W, Aggarwal BB (2012b) Discovery of curcumin, a component of golden spice, and its miraculous biological activities. Clin Exp Pharmacol Physiol 39:283–299CrossRefPubMedPubMedCentral

Gupta SC, Kismali G, Aggarwal BB (2013) Curcumin, a component of turmeric: from farm to pharmacy. Biofactors 39:2–13CrossRefPubMed

He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S et al (2005) The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci USA 102:19075–19080CrossRefPubMedPubMedCentral

Hong JM, Park CS, Nam-Goong IS, Kim YS, Lee JC, Han MW et al (2014) Curcumin enhances docetaxel-induced apoptosis of 8505 C anaplastic thyroid carcinoma cells. Endocrinol Metab 29:54–61CrossRef

John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS (2004) Human microRNA targets. PLoS Biol 2:e363CrossRefPubMedPubMedCentral

Kasashima K, Nakamura Y, Kozu T (2004) Altered expression profiles of microRNAs during TPA-induced differentiation of HL-60 cells. Biochem Biophys Res Commun 322:403–410CrossRefPubMed

Kronski E, Fiori ME, Barbieri O, Astigiano S, Mirisola V, Killian PH et al (2014) miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and-2. Mol Oncol 8:581–595CrossRefPubMed

Lewis BP, Shih I-, Jones-Rhoades MW, Bartel DP, Burge CB (2003) Prediction of mammalian microRNA targets. Cell 115:787–798CrossRefPubMed

Li F, Sethi G (2010) Targeting transcription factor NF-κκB to overcome chemoresistance and radioresistance in cancer therapy. Biochimica et Biophysica Acta (BBA)-Rev Cancer 1805:167–180CrossRef

Li S, Liang Z, Xu L, Zou F (2012) MicroRNA-21: a ubiquitously expressed pro-survival factor in cancer and other diseases. Mol Cell Biochem 360:147–158CrossRefPubMed

Liu Y, Chang RL, Cui XX, Newmark HL, Conney AH (1996) Synergistic effects of curcumin on all-trans retinoic acid-and 1 alpha, 25-dihydroxyvitamin D3-induced differentiation in human promyelocytic leukemia HL-60 cells. Oncol Res 9:19–29

Ma X, Buscaglia LEB, Barker JR, Li Y (2011) MicroRNAs in NF-$\kappa$B signaling. J Mol Cell Biol 3:159–166CrossRefPubMedPubMedCentral

Martirosyan A, Leonard S, Shi X, Griffith B, Gannett P, Strobl J (2006) Actions of a histone deacetylase inhibitor NSC3852 (5-nitroso-8-quinolinol) link reactive oxygen species to cell differentiation and apoptosis in MCF-7 human mammary tumor cells. J Pharmacol Exp Ther 317:546–552CrossRefPubMed

Mercurio F, Manning AM (1999) NF-kappaB as a primary regulator of the stress response. Oncogene 18:6163–6171CrossRefPubMed

Monticelli S, Ansel KM, Xiao C, Socci ND, Krichevsky AM, Thai T-H et al (2005) MicroRNA profiling of the murine hematopoietic system. Genome Biol 6:R71CrossRefPubMedPubMedCentral

Mudduluru G, George-William J, Muppala S, Asangani I, Kumarswamy R, Nelson L et al (2011) Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer. Biosci Rep 31:185–197CrossRefPubMed

Park J-W, Clark OH (2004) Redifferentiation therapy for thyroid cancer. Surg Clin North Am 84:921–943CrossRefPubMed

Place RF, Li L-C, Pookot D, Noonan EJ, Dahiya R (2008) MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci 105:1608–1613CrossRefPubMedPubMedCentral

Poncin S, Colin IM, Gerard AC (2009) Minimal oxidative load: a prerequisite for thyroid cell function. J Endocrinol 201:161–167CrossRefPubMed

Presta I, Arturi F, Ferretti E, Mattei T, Scarpelli D, Tosi E et al (2005) Recovery of NIS expression in thyroid cancer cells by overexpression of Pax8 gene. BMC Cancer 5:80CrossRefPubMedPubMedCentral

Raffoul JJ, Wang Y, Kucuk O, Forman JD, Sarkar FH, Hillman GG (2006) Genistein inhibits radiation-induced activation of NF-$\kappa$B in prostate cancer cells promoting apoptosis and G 2/M cell cycle arrest. BMC Cancer 6:1CrossRef

Sato A, Kudo C, Yamakoshi H, Uehara Y, Ohori H, Ishioka C et al (2011) Curcumin analog GO-Y030 is a novel inhibitor of IKK$\beta$ that suppresses NF-$\kappa$B signaling and induces apoptosis. Cancer Sci 102:1045–1051CrossRefPubMed

Schwertheim S, Sheu SY, Worm K, Grabellus F, Schmid KW (2009) Analysis of deregulated miRNAs is helpful to distinguish poorly differentiated thyroid carcinoma from papillary thyroid carcinoma. Horm Metab Res 41:475–481CrossRefPubMed

Scott GK, Mattie MD, Berger CE, Benz SC, Benz CC (2006) Rapid alteration of microRNA levels by histone deacetylase inhibition. Cancer Res 66:1277–1281CrossRefPubMed

Sheu SY, Vogel E, Worm K, Grabellus F, Schwertheim S, Schmid KW (2010) Hyalinizing trabecular tumour of the thyroid—differential expression of distinct miRNAs compared with papillary thyroid carcinoma. Histopathology 56:632–640CrossRefPubMed

Sobrinho-Simoes M, Albores-Saavedra J, Tallini G, Santoro M, Volante M, Pilotti S et al. (2004) Poorly differentiated carcinoma. World Health Organization Classification of Tumors: Pathology and Genetics of Tumours of Endocrine Organs 73–76

Song F, Zhang L, Yu H-X, Lu R-R, Bao J-D, Tan C et al (2012) The mechanism underlying proliferation-inhibitory and apoptosis-inducing effects of curcumin on papillary thyroid cancer cells. Food Chem 132:43–50CrossRefPubMed

Soubani O, Ali AS, Logna F, Ali S, Philip PA, Sarkar FH (2012) Re-expression of miR-200 by novel approaches regulates the expression of PTEN and MT1-MMP in pancreatic cancer. Carcinogenesis 33:1563–1571CrossRefPubMedPubMedCentral

Sun M, Estrov Z, Ji Y, Coombes KR, Harris DH, Kurzrock R (2008) Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells. Mol Cancer Ther 7:464–473CrossRefPubMed

Teiten M-H, Dicato M, Diederich M (2013) Curcumin as a regulator of epigenetic events. Mol Nutr Food Res 57:1619–1629CrossRefPubMed

van Staveren WCG, Solis DW, Delys L, Duprez L, Andry G, Franc B et al (2007) Human thyroid tumor cell lines derived from different tumor types present a common dedifferentiated phenotype. Cancer Res 67:8113–8120CrossRefPubMed

Vasudevan S, Tong Y, Steitz JA (2007) Switching from repression to activation: microRNAs can up-regulate translation. Science 318:1931–1934CrossRefPubMed

Viola D, Valerio L, Molinaro E, Agate L, Bottici V, Biagini A et al. (2016) Treatment of advanced thyroid cancer with targeted therapies: ten years of experience. Endocr Relat cancer 23:R185–R205CrossRefPubMed

Visconti R, Cerutti J, Battista S, Fedele M, Trapasso F, Zeki K et al (1997) Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFkappaB p65 protein expression. Oncogene 15:1987–1994CrossRefPubMed

Visone R, Pallante P, Vecchione A, Cirombella R, Ferracin M, Ferraro A et al (2007) Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene 26:7590–7595CrossRefPubMed

Vriens MR, Weng J, Suh I, Huynh N, Guerrero MA, Shen WT et al (2012) MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer. Cancer 118:3426–3432CrossRefPubMed

Wei C, Kim I-K, Kumar S, Jayasinghe S, Hong N, Castoldi G et al (2013) NF-$\kappa$B mediated miR-26a regulation in cardiac fibrosis. J Cell Physiol 228:1433–1442CrossRefPubMed

Wendlandt EB, Graff JW, Gioannini TL, McCaffrey AP, Wilson ME (2012) The role of MicroRNAs miR-200b and miR-200c in TLR4 signaling and NF-$\kappa$B activation. Innate immunity 18:846–855CrossRefPubMedPubMedCentral

Xiong A, Yu W, Tiwary R, Sanders BG, Kline K (2012) Distinct roles of different forms of vitamin E in DHA-induced apoptosis in triple-negative breast cancer cells. Mol Nutr Food Res 56:923–934CrossRefPubMed

Zhang L, Cheng X, Gao Y, Bao J, Guan H, Lu R et al. (2016) Induction of ROS-independent DNA damage by curcumin leads to G2/M cell cycle arrest and apoptosis in human papillary thyroid carcinoma BCPAP cells. Food Funct 7:315–325CrossRefPubMed

Zhuang W, Long L, Zheng B, Ji W, Yang N, Zhang Q et al (2012) Curcumin promotes differentiation of glioma-initiating cells by inducing autophagy. Cancer Sci 103:684–690CrossRefPubMed

Title: Curcumin induces G2/M arrest, apoptosis, NF-κB inhibition, and expression of differentiation genes in thyroid carcinoma cells
Authors: Suzan Schwertheim
Frederik Wein
Klaus Lennartz
Karl Worm
Kurt Werner Schmid
Sien-Yi Sheu-Grabellus
Publication date: 01-07-2017
Publisher: Springer Berlin Heidelberg
Published in: Journal of Cancer Research and Clinical Oncology / Issue 7/2017
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-017-2380-z

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Curcumin induces G2/M arrest, apoptosis, NF-κB inhibition, and expression of differentiation genes in thyroid carcinoma cells

Abstract

Purpose

Methods

Results

Conclusions

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 7/2017

Multivariate analysis of risk factors for patients with stage 4 neuroblastoma who were older than 18 months at diagnosis: a report from a single institute in Shanghai, China

Incidence and outcomes of acute kidney injury in patients with hepatocellular carcinoma after liver transplantation

Erratum to: Curcumin induces G2/M arrest, apoptosis, NF-κB inhibition, and expression of differentiation genes in thyroid carcinoma cells

Genomic characteristics of trastuzumab-resistant Her2-positive metastatic breast cancer

Role of stereotactic body radiation therapy for lung metastases from radio-resistant primary tumours

Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page